Stem Cell Transplant
Yale New Haven Hospital is a member of the National Marrow Donor Program and is accredited as a major transplant center by the FACT transplant accreditation committee.
Autologous Stem Cell Transplant
Autologous stem cell transplant helps to rebuild bone marrow that’s injured or destroyed during high dose drug therapies used to treat some cancers.
Allogeneic Stem Cell Transplant at Yale
An allogeneic stem cell transplant involves receiving stem cells from another person (a donor).
Cutaneous T Cell Lymphoma
There are a variety of treatment options available for cutaneous T and B-cell lymphoma and many patients are able to live relatively normal lives during and following therapy. Early diagnosis, cutting-edge treatment, and novel therapies provide a significant benefit to patients with cutaneous lymphomas at Smilow Cancer Hospital and throughout the world.
CAR T-Cell Therapy Program
The CAR T-Cell Therapy Program at Smilow Cancer Hospital brings an innovative new immunotherapy treatment option to patients with certain blood cancers.
T Cell Lymphoma Program
T Cell Lymphomas have a number of different subtypes, and the hematology team at Smilow Cancer Hospital has expertise in profiling patient’s tumors to determine the specific genetic mutations so treatment can be tailored.
Myelodysplastic Syndromes (MDS) are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells.
Multiple Myeloma and Gammopathies ProgramOverall survival in patients with myeloma has shown improvement in recent years, with new treatments approved by the FDA as recently as this year.
Read More about the Multiple Myeloma Program>>
Our Smilow Classical Hematology Program offers services dedicated to benign care.